TI
BLPH

Telemetry Investments’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Telemetry Investments’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$40K Sell
44,000
-3,500
-7% -$3.58K 0.06% 105
2022
Q3 		$52K Sell
47,500
-21,500
-31% -$28.1K 0.07% 126
2022
Q2 		$85K Sell
69,000
-14,584
-17% -$19.5K 0.1% 119
2022
Q1 		$197K Sell
83,584
-19,197
-19% -$45.7K 0.31% 94
2021
Q4 		$319K Buy
102,781
+17,281
+20% +$57.4K 0.41% 83
2021
Q3 		$347K Sell
85,500
-5,420
-6% -$22.6K 0.47% 71
2021
Q2 		$440K Buy
90,920
+29,878
+49% +$134K 0.61% 56
2021
Q1 		$317K Sell
61,042
-29,842
-33% -$208K 0.36% 89
2020
Q4 		$606K Sell
90,884
-26,260
-22% -$215K 1.02% 39
2020
Q3 		$1.19M Sell
117,144
-7,856
-6% -$92.4K 2.59% 8
2020
Q2 		$1.57M Buy
125,000
+75,000
+150% +$1.05M 4.26% 3
2020
Q1 		$548K Buy
50,000
+27,467
+122% +$184K 1.91% 24
2019
Q4 		$118K Hold
22,533
– – 0.39% 38
2019
Q3 		$163K Sell
22,533
-10,104
-31% -$92.1K 0.47% 47
2019
Q2 		$293K Buy
32,637
+19,740
+153% +$189K 0.23% 61
2019
Q1 		$126K Buy
+12,897
New +$142K 0.06% 89
2018
Q4 		– Sell
-4,511
Closed -$73K – 153
2018
Q3 		$73K Sell
4,511
-5,156
-53% -$122K 0.03% 114
2018
Q2 		$351K Sell
9,667
-3,600
-27% -$125K 0.13% 76
2018
Q1 		$414K Buy
13,267
+7,972
+151% +$254K 0.16% 83
2017
Q4 		$205K Buy
+5,295
New +$139K 0.08% 113

Other funds holding BLPH

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Telemetry Investments's BLPH Position: Q4 2022 in Review

Telemetry Investments reduced its Bellerophon Therapeutics, Inc. (BLPH) stake by 7.4% in Q4 2022, selling an estimated $3.58K and leaving 44,000 shares worth $40K. The position accounts for 0.06% of the portfolio, ranked #105.

Telemetry Investments first reported a position in BLPH in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.57M in Q2 2020. 25 funds tracked by Wall St. Rank hold BLPH as of Q4 2022.

  • Telemetry Investments held 44,000 shares of Bellerophon Therapeutics, Inc. worth $40K as of Q4 2022.
  • Telemetry Investments sold 3,500 Bellerophon Therapeutics, Inc. shares in Q4 2022, an estimated $3.58K.
  • Bellerophon Therapeutics, Inc. made up 0.06% of Telemetry Investments's portfolio in Q4 2022, its #105 holding.
  • Telemetry Investments first reported a position in Bellerophon Therapeutics, Inc. in Q4 2017 and has held it in 20 quarters since.
  • Telemetry Investments's Bellerophon Therapeutics, Inc. position peaked at $1.57M in Q2 2020.
  • 25 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.